Literature DB >> 21056660

An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier.

Andrea D Lehmann1, Nicole Daum, Michael Bur, Claus-Michael Lehr, Peter Gehr, Barbara M Rothen-Rutishauser.   

Abstract

A triple cell co-culture model was recently established by the authors, consisting of either A549 or 16HBE14o- epithelial cells, human blood monocyte-derived macrophages and dendritic cells, which offers the possibility to study the interaction of xenobiotics with those cells. The 16HBE14o- containing co-culture model mimics the airway epithelial barrier, whereas the A549 co-cultures mimic the alveolar type II-like epithelial barrier. The goal of the present work was to establish a new triple cell co-culture model composed of primary alveolar type I-like cells isolated from human lung biopsies (hAEpC) representing a more realistic alveolar epithelial barrier wall, since type I epithelial cells cover >93% of the alveolar surface. Monocultures of A549 and 16HBE14o- were morphologically and functionally compared with the hAEpC using laser scanning microscopy, as well as transmission electron microscopy, and by determining the epithelial integrity. The triple cell co-cultures were characterized using the same methods. It could be shown that the epithelial integrity of hAEpC (mean ± SD, 1180 ± 188 Ω cm(2)) was higher than in A549 (172 ± 59 Ω cm(2)) but similar to 16HBE14o- cells (1469 ± 156 Ω cm(2)). The triple cell co-culture model with hAEpC (1113 ± 30 Ω cm(2)) showed the highest integrity compared to the ones with A549 (93 ± 14 Ω cm(2)) and 16HBE14o- (558 ± 267 Ω cm(2)). The tight junction protein zonula occludens-1 in hAEpC and 16HBE14o- were more regularly expressed but not in A549. The epithelial alveolar model with hAEpC combined with two immune cells (i.e. macrophages and dendritic cells) will offer a novel and more realistic cell co-culture system to study possible cell interactions of inhaled xenobiotics and their toxic potential on the human alveolar type I epithelial wall.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056660     DOI: 10.1016/j.ejpb.2010.10.014

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  24 in total

1.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

2.  Biomimetics of fetal alveolar flow phenomena using microfluidics.

Authors:  Janna Tenenbaum-Katan; Rami Fishler; Barbara Rothen-Rutishauser; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2015-02-17       Impact factor: 2.800

Review 3.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

Review 4.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

Authors:  Uwe Marx; Tommy B Andersson; Anthony Bahinski; Mario Beilmann; Sonja Beken; Flemming R Cassee; Murat Cirit; Mardas Daneshian; Susan Fitzpatrick; Olivier Frey; Claudia Gaertner; Christoph Giese; Linda Griffith; Thomas Hartung; Minne B Heringa; Julia Hoeng; Wim H de Jong; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Andreas Luch; Ilka Maschmeyer; Dmitry Sakharov; Adrienne J A M Sips; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Tewes Tralau; Sergej Tsyb; Anja van de Stolpe; Rob Vandebriel; Paul Vulto; Jufeng Wang; Joachim Wiest; Marleen Rodenburg; Adrian Roth
Journal:  ALTEX       Date:  2016-05-15       Impact factor: 6.043

5.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.

Authors:  Amy J Clippinger; David Allen; Annie M Jarabek; Marco Corvaro; Marianna Gaça; Sean Gehen; Jon A Hotchkiss; Grace Patlewicz; Jodie Melbourne; Paul Hinderliter; Miyoung Yoon; Dongeun Huh; Anna Lowit; Barbara Buckley; Michael Bartels; Kelly BéruBé; Daniel M Wilson; Ian Indans; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2017-12-22       Impact factor: 3.500

6.  Toxicological analysis of limonene reaction products using an in vitro exposure system.

Authors:  Stacey E Anderson; Shahana S Khurshid; B Jean Meade; Ewa Lukomska; J R Wells
Journal:  Toxicol In Vitro       Date:  2012-12-07       Impact factor: 3.500

7.  An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO₂ inhalation exposures.

Authors:  Philip Demokritou; Samuel Gass; Georgios Pyrgiotakis; Joel M Cohen; William Goldsmith; Walt McKinney; David Frazer; Jane Ma; Diane Schwegler-Berry; Joseph Brain; Vincent Castranova
Journal:  Nanotoxicology       Date:  2012-11-08       Impact factor: 5.913

8.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

9.  Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro.

Authors:  Joel M Cohen; Raymond Derk; Liying Wang; John Godleski; Lester Kobzik; Joseph Brain; Philip Demokritou
Journal:  Nanotoxicology       Date:  2014-01-30       Impact factor: 5.913

Review 10.  Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Authors:  Aurélie Crabbé; Maria A Ledesma; Cheryl A Nickerson
Journal:  Pathog Dis       Date:  2014-05-23       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.